Strong oxidizers can degrade copper peptides
The degradation process of tryptophan in KP produces a variety of neuroactive metabolites with amino acid-like structures, such as an N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid (QA), and a neuroprotective NMDA receptor agonist kynurenic acid (KYNA)
It is approved for adolescents aged 12 and older, which Wegovy is not
You can see my testimony at the PCAC if you watch the live stream or the pre-recorded version on youtube at: Also our 5 risks of peptides, like bpc-157, is a useful resource in this area: I really think the FDA will ultimately ignore the opinion of the largely financially conflicted PCAC
By purchasing from Panda Peptides, you acknowledge that you are acquiring a research chemical
Where can I source the blend with a documented certificate of analysis